ReviewJournal of chest surgery2026
Tumor Spread through Air Spaces in Early-Stage Lung Adenocarcinoma: Surgical Implications and Patient Management Strategies.
Review in Journal of chest surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tumor spread through air spaces (STAS) is a recently recognized, clinically relevant invasive pattern in lung adenocarcinoma with important prognostic implications. Recognition of STAS has influenced ongoing discussions regarding the surgical management of non-small cell lung cancer. The International Association for the Study of Lung Cancer Staging Project recently recommended adopting STAS as a histologic T descriptor in the 9th edition of the tumor-node-metastasis (TNM) classification. Moving beyond its role as a morphological risk factor, recent studies suggest that STAS may serve not only as a prognostic marker but also as a potential indicator of divergent evolutionary trajectories shaped by underlying driver mutations. This review summarizes the morphological definitions of STAS, its observed impact on outcomes after sublobar resection, optimization of surgical margin distance, challenges in intraoperative diagnosis, differential prevalence according to genetic alterations, and proposed integration into the 9th edition of the TNM classification. Potential clinical considerations for risk stratification and patient management based on STAS are also discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.